Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications

In light of the outbreak of the 2019 novel coronavirus disease (COVID-19), the international scientific community has joined forces to develop effective treatment strategies. The Angiotensin-Converting Enzyme (ACE) 2, is an essential receptor for cell fusion and engulfs the SARS coronavirus infections. ACE2 plays an important physiological role, practically in all the organs and systems. Also, ACE2 exerts protective functions in various models of pathologies with acute and chronic inflammation. While ACE2 downregulation by SARS-CoV-2 spike protein leads to an overactivation of Angiotensin (Ang) II/AT1R axis and the deleterious effects of Ang II may explain the multiorgan dysfunction seen in patients. Specifically, the role of Ang II leading to the appearance of Macrophage Activation Syndrome (MAS) and the cytokine storm in COVID-19 is discussed below. In this review, we summarized the latest research progress in the strategies of treatments that mainly focus on reducing the Ang II-induced deleterious effects rather than attenuating the virus replication.

[1]  T. Tabuchi,et al.  Coronavirus Disease , 2021, Encyclopedia of the UN Sustainable Development Goals.

[2]  M. Benekli,et al.  Thrombopoietin as a Drug: Biologic Expectations, Clinical Realities, and Future Directions , 2002, Clinical and applied thrombosis/hemostasis.

[3]  F. van Lente,et al.  Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. , 2008, Journal of the American College of Cardiology.

[4]  H. Okano,et al.  Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. , 2006, Investigative ophthalmology & visual science.

[5]  M. Zenke,et al.  Immunosuppressive treatment protects against angiotensin II-induced renal damage. , 2002, The American journal of pathology.

[6]  H. Kai,et al.  Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 , 2020, Hypertension Research.

[7]  K. Nichols,et al.  The Immunology of Macrophage Activation Syndrome , 2019, Front. Immunol..

[8]  Taojiao Wang,et al.  Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.

[9]  C. Spies,et al.  Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury , 2018, Journal of inflammation research.

[10]  J. Hugot,et al.  Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[11]  J. Ménard,et al.  Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. , 1996, The Journal of clinical investigation.

[12]  Arthur S Slutsky,et al.  Angiotensin-converting enzyme 2 protects from severe acute lung failure , 2005, Nature.

[13]  E. Scott,et al.  Angiotensin II Regulation of Proliferation, Differentiation, and Engraftment of Hematopoietic Stem Cells , 2016, Hypertension.

[14]  A. Daugherty,et al.  Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice. , 2019, Journal of vascular surgery.

[15]  H. Cooper,et al.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[16]  Yongyan Shi,et al.  AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease , 2015, Molecular medicine reports.

[17]  F. Thaiss,et al.  Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. , 1997, The Journal of clinical investigation.

[18]  K. Clark,et al.  Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme , 2002, FEBS letters.

[19]  N. Hooper,et al.  The angiotensin-converting enzyme gene family: genomics and pharmacology. , 2002, Trends in pharmacological sciences.

[20]  Raphael Nudelman,et al.  Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis , 2008, Nature Clinical Practice Rheumatology.

[21]  Qin Ning,et al.  Clinical and immunological features of severe and moderate coronavirus disease 2019 , 2020 .

[22]  C. Chen,et al.  Angiotensin-converting enzyme 2 regulates mitochondrial function in pancreatic β-cells. , 2018, Biochemical and biophysical research communications.

[23]  A. B. Singh,et al.  Retinoic acid protects cardiomyocytes from high glucose‐induced apoptosis through inhibition of NF‐κB signaling Pathway , 2013, Journal of cellular physiology.

[24]  A. Yachie,et al.  Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis , 2018, Cytokine.

[25]  P. Datta,et al.  Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells. , 1999, Kidney international.

[26]  M. Ramanathan,et al.  Telmisartan attenuated LPS-induced neuroinflammation in human IMR-32 neuronal cell line via SARM in AT1R independent mechanism. , 2015, Life sciences.

[27]  J. Priller,et al.  Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium. , 2002, American journal of respiratory cell and molecular biology.

[28]  W. Tang,et al.  Angiotensin-Converting Enzyme 2 as a Therapeutic Target for Heart Failure , 2013, Current Heart Failure Reports.

[29]  R. Kruse.  Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China , 2020, F1000Research.

[30]  G. Bedse,et al.  The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury , 2018, Front. Physiol..

[31]  D. Foell,et al.  Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. , 2018, Blood.

[32]  B. Markovitz,et al.  Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults. , 2000, The Cochrane database of systematic reviews.

[33]  K. Miura,et al.  Role of renin-angiotensin system and nuclear factor-kappaB in the obstructed kidney of rats with unilateral ureteral obstruction. , 2002, Japanese journal of pharmacology.

[34]  Dong-yang Huang,et al.  Upregulation of Angiotensin-Converting Enzyme 2 by All-trans Retinoic Acid in Spontaneously Hypertensive Rats , 2004, Hypertension.

[35]  J. Palmblad,et al.  Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure? , 1999, Journal of internal medicine.

[36]  S. Perlman,et al.  ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia , 2005, Journal of Virology.

[37]  Quynh Nguyen,et al.  Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System , 2020, Circulation research.

[38]  P. Esbrit,et al.  Angiotensin II increases parathyroid hormone-related protein (PTHrP) and the type 1 PTH/PTHrP receptor in the kidney. , 2002, Journal of the American Society of Nephrology : JASN.

[39]  U. Kukongviriyapan,et al.  Effect of asiatic acid on the Ang II-AT1R-NADPH oxidase-NF-κB pathway in renovascular hypertensive rats , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.

[40]  P. Dempsey,et al.  ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[41]  Angiotensin II AT1 Receptor Blockade Decreases Brain Artery Inflammation in a Stress‐Prone Rat Strain , 2004, Annals of the New York Academy of Sciences.

[42]  S. Uhlig,et al.  A Disintegrin and Metalloproteinase 17 (ADAM17) Mediates Inflammation-induced Shedding of Syndecan-1 and -4 by Lung Epithelial Cells* , 2009, The Journal of Biological Chemistry.

[43]  K. Horiuchi,et al.  ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface. , 2015, Cytokine.

[44]  N. Vaziri,et al.  Intra-Renal Angiotensin II/AT1 Receptor, Oxidative Stress, Inflammation, and Progressive Injury in Renal Mass Reduction , 2007, Journal of Pharmacology and Experimental Therapeutics.

[45]  J. Winkler,et al.  Role of the receptor Mas in macrophage-mediated inflammation in vivo , 2016, Proceedings of the National Academy of Sciences.

[46]  Q. Ma,et al.  Upregulation of angiotensin‐converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors , 2010, Clinical and experimental pharmacology & physiology.

[47]  Ali Nehme,et al.  Atlas of tissue renin-angiotensin-aldosterone system in human: A transcriptomic meta-analysis , 2015, Scientific Reports.

[48]  G. Filippatos,et al.  Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[49]  A. Takakura,et al.  Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. , 2007, Journal of the American Society of Nephrology : JASN.

[50]  D. Stewart,et al.  Competing Interests: This work was , 2022 .

[51]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.

[52]  S. Waltz,et al.  RON RECEPTOR TYROSINE KINASE NEGATIVELY REGULATES TNF&agr; PRODUCTION IN ALVEOLAR MACROPHAGES BY INHIBITING NF-&kgr;B ACTIVITY AND ADAM17 PRODUCTION , 2010, Shock.

[53]  D. Granger,et al.  Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature. , 2007, American journal of physiology. Heart and circulatory physiology.

[54]  Arthur S Slutsky,et al.  Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target , 2020, Intensive Care Medicine.

[55]  J. Saavedra,et al.  Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathways , 2012, Journal of Neuroinflammation.

[56]  K. Horiuchi,et al.  Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide , 2012, EMBO molecular medicine.

[57]  D. McGonagle,et al.  The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease , 2020, Autoimmunity Reviews.

[58]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[59]  J. Tavernier,et al.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases , 2016, Microbiology and Molecular Reviews.

[60]  J. Cui,et al.  ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism , 2020, medRxiv.

[61]  H. Im,et al.  Central nervous system (CNS) involvement is a critical prognostic factor for hemophagocytic lymphohistiocytosis , 2012, The Korean journal of hematology.

[62]  Chuan Qin,et al.  Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[63]  P. Schirmacher,et al.  Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice , 2010, The Journal of experimental medicine.

[64]  J. Arribas,et al.  ADAM17 as a therapeutic target in multiple diseases. , 2009, Current pharmaceutical design.

[65]  C. Sobey,et al.  Evidence that macrophages in atherosclerotic lesions contain angiotensin II. , 1998, Circulation.

[66]  Yi Yang,et al.  Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury , 2015, Cell transplantation.

[67]  M. Crackower,et al.  Angiotensin-converting enzyme 2 is an essential regulator of heart function , 2002, Nature.

[68]  B. Uhal,et al.  Angiotensin signalling in pulmonary fibrosis. , 2012, The international journal of biochemistry & cell biology.

[69]  A. Zernecke,et al.  Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. , 2009, Blood.

[70]  L. Gakhar,et al.  Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[71]  M. Iwai,et al.  Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis , 2009, Hypertension Research.

[72]  M. Teixeira,et al.  Angiotensin-(1-7) and Alamandine Promote Anti-inflammatory Response in Macrophages In Vitro and In Vivo , 2019, Mediators of inflammation.

[73]  D. Brenner,et al.  Angiotensin‐converting‐enzyme 2 inhibits liver fibrosis in mice , 2009, Hepatology.

[74]  M. Roussel,et al.  TNF Counterbalances the Emergence of M2 Tumor Macrophages. , 2015, Cell reports.

[75]  A. Murphy,et al.  Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture , 2017, Cardiovascular Drugs and Therapy.

[76]  Jinkui Yang,et al.  The ACE2/Ang-(1–7)/Mas axis can inhibit hepatic insulin resistance , 2014, Molecular and Cellular Endocrinology.

[77]  Gang Liu,et al.  Mesenchymal Stem Cells Modified with Angiotensin-Converting Enzyme 2 are Superior for Amelioration of Glomerular Fibrosis in Diabetic Nephropathy. , 2020, Diabetes research and clinical practice.

[78]  Marta Ruiz-Ortega,et al.  Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. , 2002, Kidney international. Supplement.

[79]  C. Libert,et al.  New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. , 2013, Endocrinology.

[80]  U. Das.  Renin–angiotensin–aldosterone system in insulin resistance and metabolic syndrome , 2016, Journal of translational internal medicine.

[81]  R. Henning,et al.  Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats , 2002, Circulation.

[82]  L. Navar,et al.  Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure , 2018, Current Hypertension Reports.

[83]  Michael H. Rabinowitz,et al.  Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. , 2001, The Journal of pharmacology and experimental therapeutics.

[84]  T. Ogihara,et al.  Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. , 1999, Journal of hypertension.

[85]  Christian Drosten,et al.  Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 , 2009, Journal of Virology.

[86]  M. Freeman,et al.  Tumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACE , 2012, Science.

[87]  R. Weissleder,et al.  Angiotensin-Converting Enzyme Inhibition Prevents the Release of Monocytes From Their Splenic Reservoir in Mice With Myocardial Infarction , 2010, Circulation research.

[88]  Mark Chappell,et al.  A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.

[89]  Bibekanand Mallick,et al.  MicroRNome Analysis Unravels the Molecular Basis of SARS Infection in Bronchoalveolar Stem Cells , 2009, PloS one.

[90]  T. Nakajima,et al.  Losartan inhibits LPS-induced inflammatory signaling through a PPARγ-dependent mechanism in human THP-1 macrophages , 2010, Hypertension Research.

[91]  M. Moss,et al.  Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation , 2017, Mediators of inflammation.

[92]  M. Raizada,et al.  Angiotensin II causes imbalance between pro‐ and anti‐inflammatory cytokines by modulating GSK‐3β in neuronal culture , 2013, British journal of pharmacology.

[93]  H. Hemmi,et al.  Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[94]  G. Chrousos,et al.  Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[95]  Yusuke Suzuki,et al.  Proinflammatory actions of angiotensins , 2001, Current opinion in nephrology and hypertension.

[96]  J. Penninger,et al.  Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction , 2010, Circulation.

[97]  P. Zhu,et al.  Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus , 2016, Scientific Reports.

[98]  H. Kawachi,et al.  Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis. , 2002, Kidney international.

[99]  B. Markovitz,et al.  Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults. , 2008, The Cochrane database of systematic reviews.

[100]  Jeroen J. Bax,et al.  Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation. , 2010, European Heart Journal.

[101]  G. Viglianti,et al.  Nuclear Receptor Signaling Inhibits HIV-1 Replication in Macrophages through Multiple trans-Repression Mechanisms , 2011, Journal of Virology.

[102]  A. Loeckinger,et al.  Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxia. , 2012, Wilderness & environmental medicine.

[103]  C. Libert,et al.  Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation. , 2012, The Journal of clinical investigation.

[104]  J. Penninger,et al.  Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy , 2012, Laboratory Investigation.

[105]  J. Mehta,et al.  Cross-talk between inflammation and angiotensin II: Studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA , 2012, Experimental biology and medicine.

[106]  B. Rollins,et al.  CCL2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory Responses Critical to Healing Myocardial Infarcts , 2005, Circulation research.

[107]  K. Takeda,et al.  Downregulation of angiotensin II type 1 receptor by all-trans retinoic acid in vascular smooth muscle cells. , 2000, Hypertension.

[108]  B. Greenberg.  Clinical ResearchHeart Failure: Editorial CommentAn ACE in the Hole: Alternative Pathways of the Renin Angiotensin System and Their Potential Role in Cardiac Remodeling⁎ , 2008 .

[109]  L. Bladh,et al.  Herpes simplex virus type 1 infection and glucocorticoid treatment regulate viral yield, glucocorticoid receptor and NF-kappaB levels. , 2002, The Journal of endocrinology.

[110]  T. Sasazuki,et al.  TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds , 2009, Antiviral Research.

[111]  Koji Yamada,et al.  Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease , 2010, Brain Research.

[112]  C. Weber,et al.  Requirements for leukocyte transmigration via the transmembrane chemokine CX3CL1 , 2010, Cellular and Molecular Life Sciences.

[113]  Masami Goto,et al.  Addition of Eplerenone to an Angiotensin-Converting Enzyme Inhibitor Effectively Improves Nitric Oxide Bioavailability , 2008, Hypertension.

[114]  Richard L. Amdur,et al.  Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial* , 2016, Critical care medicine.

[115]  B. Jiang,et al.  Three key proteases – angiotensin-I-converting enzyme (ACE), ACE2 and renin – within and beyond the renin-angiotensin system , 2012, Archives of Cardiovascular Diseases.

[116]  L. Dworkin,et al.  Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade. , 2008, Kidney international.

[117]  T. Yamashita,et al.  TACE cleaves neogenin to desensitize cortical neurons to the repulsive guidance molecule , 2011, Neuroscience Research.

[118]  H. Jia.  Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease , 2016, Shock.

[119]  E. Fleck,et al.  Angiotensin II Induces Migration and Pyk2/Paxillin Phosphorylation of Human Monocytes , 2001, Hypertension.

[120]  L. Veinotte,et al.  CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control , 2016, Oncoimmunology.

[121]  J. Kwon,et al.  T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation , 2004, Nature Immunology.

[122]  J. Penninger,et al.  Angiotensin-converting enzyme II in the heart and the kidney. , 2006, Circulation research.

[123]  A. Loeckinger,et al.  Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets , 2010, Critical care medicine.

[124]  E. Lazartigues,et al.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[125]  P. Barnes,et al.  Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.

[126]  Lina Zhang,et al.  Angiotensin-(1-7)/Mas Signaling Inhibits Lipopolysaccharide-Induced ADAM17 Shedding Activity and Apoptosis in Alveolar Epithelial Cells , 2015, Pharmacology.

[127]  Z. Li,et al.  Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS† , 2006, The Journal of pathology.

[128]  J. Karn,et al.  The Glucocorticoid Receptor Is a Critical Regulator of HIV Latency in Human Microglial Cells , 2018, Journal of Neuroimmune Pharmacology.

[129]  C. Caruso,et al.  Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia , 2020, Aging and disease.

[130]  D. Diz,et al.  COVID-19, ACE2, and the cardiovascular consequences , 2020, American journal of physiology. Heart and circulatory physiology.

[131]  D. Ganten,et al.  NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. , 2000, Hypertension.

[132]  S. Rose-John.  ADAM17, shedding, TACE as therapeutic targets. , 2013, Pharmacological research.

[133]  S. Özen,et al.  Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature , 2018, Clinical Rheumatology.

[134]  Huadong Zhu,et al.  miRNA-200c-3p is crucial in acute respiratory distress syndrome , 2017, Cell Discovery.

[135]  S. Martínez-Hervás,et al.  Functional role of endothelial CXCL16/CXCR6-platelet–leucocyte axis in angiotensin II-associated metabolic disorders , 2018, Cardiovascular research.

[136]  U. Khoo,et al.  A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung , 2007, The Journal of experimental medicine.

[137]  B. Brenner,et al.  Renal allograft protection with losartan in Fisher-->Lewis rats: hemodynamics, macrophages, and cytokines. , 2000, Kidney international.

[138]  A. Daugherty,et al.  Angiotensin-Converting Enzyme 2 Deficiency in Whole Body or Bone Marrow–Derived Cells Increases Atherosclerosis in Low-Density Lipoprotein Receptor−/− Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[139]  Y. Takikawa,et al.  A disintegrin and metalloproteinase 17 (ADAM17) mediates epidermal growth factor receptor transactivation by angiotensin II on hepatic stellate cells. , 2014, Life sciences.

[140]  A. Martini,et al.  Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. , 2005, The Journal of pediatrics.

[141]  Jennifer L. Brazzell,et al.  ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding. , 2006, Blood.

[142]  S. Eguchi,et al.  AT1 receptor signaling pathways in the cardiovascular system , 2017, Pharmacological research.

[143]  E. Debnam,et al.  Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport. , 2012, American journal of physiology. Endocrinology and metabolism.

[144]  D. Ganten,et al.  Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats. , 1999, Journal of cardiovascular pharmacology.

[145]  T. Wyss-Coray,et al.  Angiotensin II sustains brain inflammation in mice via TGF-beta. , 2010, The Journal of clinical investigation.

[146]  J. Penninger,et al.  Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury , 2012, Journal of Molecular Medicine.

[147]  T. Sugawara,et al.  Candesartan reduces superoxide production after global cerebral ischemia , 2005, Neuroreport.

[148]  Dandan Wu,et al.  TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib , 2020, Journal of Microbiology, Immunology and Infection.

[149]  B. Uhal,et al.  Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[150]  H. Balfour,et al.  Primary EBV Infection Induces an Expression Profile Distinct from Other Viruses but Similar to Hemophagocytic Syndromes , 2014, PloS one.

[151]  N. Hooper,et al.  Tumor Necrosis Factor-α Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2) , 2005, Journal of Biological Chemistry.

[152]  E. Raines,et al.  Macrophage ADAM17 Deficiency Augments CD36-Dependent Apoptotic Cell Uptake and the Linked Anti-Inflammatory Phenotype , 2013, Circulation research.

[153]  G. Oudit,et al.  Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. , 2014, Journal of molecular and cellular cardiology.

[154]  Shi Hu,et al.  Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig , 2020, bioRxiv.

[155]  Jie Dong,et al.  Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients , 2020, Cell Host & Microbe.

[156]  Wei Hu,et al.  Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway , 2015, BioMed research international.

[157]  J. Saavedra,et al.  Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-&ggr; activation in human monocytes , 2012, Journal of hypertension.

[158]  Marc A Pfeffer,et al.  Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 , 2020, The New England journal of medicine.

[159]  E. Johns,et al.  Effect of beta(2)-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells. , 1999, Cytokine.

[160]  D. Ganten,et al.  NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in Rats , 2000 .

[161]  Butsabong Lerkvaleekul,et al.  Macrophage activation syndrome: early diagnosis is key , 2018, Open access rheumatology : research and reviews.

[162]  B. Uhal,et al.  Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages. , 2007, Current pharmaceutical design.

[163]  J. Penninger,et al.  ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity , 2015, Diabetes.

[164]  Jinkui Yang,et al.  Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis , 2016, Scientific Reports.

[165]  D. Ganten,et al.  Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. , 2000, The American journal of pathology.

[166]  J. Egido,et al.  Angiotensin II and renal fibrosis. , 2001, Hypertension.

[167]  Z. Abassi,et al.  Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure Patients , 2005, Circulation research.

[168]  N. Kittana.  Angiotensin‐converting enzyme 2–Angiotensin 1‐7/1‐9 system: novel promising targets for heart failure treatment , 2018, Fundamental & clinical pharmacology.

[169]  R. Gao,et al.  Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections , 2014, Nature Communications.

[170]  K. Miura,et al.  Role of Renin-Angiotensin System and Nuclear Factor-κB in the Obstructed Kidney of Rats With Unilateral Ureteral Obstruction , 2002 .

[171]  P. Angus,et al.  Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2 , 2005, Gut.

[172]  Suresh Patel,et al.  COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features , 2020, Radiology.

[173]  Fengying Gao,et al.  The functional study of human umbilical cord mesenchymal stem cells harbouring angiotensin‐converting enzyme 2 in rat acute lung ischemia‐reperfusion injury model , 2014, Cell biochemistry and function.

[174]  J. Penninger,et al.  Recombinant Human Angiotensin-Converting Enzyme 2 as a New Renin-Angiotensin System Peptidase for Heart Failure Therapy , 2011, Current heart failure reports.

[175]  A. Randolph,et al.  Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults. , 2009, The Cochrane database of systematic reviews.

[176]  R. Niimi,et al.  Suppression of endotoxin-induced renal tumor necrosis factor-alpha and interleukin-6 mRNA by renin-angiotensin system inhibitors. , 2002, Japanese journal of pharmacology.

[177]  P. Robbins,et al.  SIRT1 Negatively Regulates the Mammalian Target of Rapamycin , 2010, PloS one.

[178]  R. Berthier,et al.  The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654). , 1996, Experimental hematology.

[179]  K. Chu,et al.  Cerebral autoinflammatory disease treated with anakinra , 2018, Annals of clinical and translational neurology.

[180]  Takemi Tanaka,et al.  Retinoic acid receptor‐mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: Role of the renin‐angiotensin system , 2011, Journal of cellular physiology.

[181]  X. Chen,et al.  Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression. , 2013, The Canadian journal of cardiology.

[182]  Y. Pei,et al.  Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome. , 2017, Kidney international.

[183]  R. Santos,et al.  Brain-Selective Overexpression of Human Angiotensin-Converting Enzyme Type 2 Attenuates Neurogenic Hypertension , 2010, Circulation research.

[184]  G. Schulert,et al.  Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. , 2015, Annual review of medicine.

[185]  J. Egido,et al.  Connective Tissue Growth Factor Is a Mediator of Angiotensin II–Induced Fibrosis , 2003, Circulation.

[186]  G. Oudit,et al.  Cardioprotective Effects Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin 1-7 in Experimental Heart Failure in Angiotensin-Converting Enzyme 2–Null Mice , 2012, Hypertension.

[187]  Chun-Hsu Pan,et al.  Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts , 2010, Peptides.

[188]  S. Bagshaw,et al.  Corticosteroids to prevent extubation failure: a systematic review and meta-analysis , 2009, Intensive Care Medicine.

[189]  Jing Yuan,et al.  Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury , 2020, Science China Life Sciences.

[190]  B. Uhal,et al.  Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[191]  J. Taylor,et al.  Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-β (TGF-β) and α-actomyosin (α SMA), important mediators of radiation-induced pneumopathy and lung fibrosis , 2007 .

[192]  Stefan Rose-John,et al.  ADAM17: a molecular switch to control inflammation and tissue regeneration. , 2011, Trends in immunology.

[193]  R. Khokha,et al.  Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. , 2007, Cardiovascular research.

[194]  J. Penninger,et al.  Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2 , 2011, Hypertension.

[195]  M. Freeman,et al.  Neutrophil and Macrophage Cell Surface Colony-Stimulating Factor 1 Shed by ADAM17 Drives Mouse Macrophage Proliferation in Acute and Chronic Inflammation , 2018, Molecular and Cellular Biology.

[196]  R. Summer,et al.  Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension. , 2015, Life sciences.

[197]  A. Descoteaux,et al.  Macrophage Cytokines: Involvement in Immunity and Infectious Diseases , 2014, Front. Immunol..

[198]  G. Haegeman,et al.  The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. , 2003, Endocrine reviews.

[199]  Josef M. Penninger,et al.  Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters , 2010, Pharmacology & Therapeutics.

[200]  S. Sriramula,et al.  Brain-Targeted Angiotensin-Converting Enzyme 2 Overexpression Attenuates Neurogenic Hypertension by Inhibiting Cyclooxygenase-Mediated Inflammation , 2015, Hypertension.

[201]  Kavaljit H. Chhabra,et al.  Brain Angiotensin-Converting Enzyme Type 2 Shedding Contributes to the Development of Neurogenic Hypertension , 2013, Circulation research.

[202]  Yan Wang,et al.  Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19 , 2020, Journal of medical virology.

[203]  M. Raizada,et al.  Cerebroprotection by angiotensin‐(1–7) in endothelin‐1‐induced ischaemic stroke , 2011, Experimental physiology.

[204]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[205]  T. Gwathmey,et al.  SPECIAL TOPIC Intracrine Renin-Angiotensin System: A New Paradigm in Cardiovascular and Renal Control Novel roles of nuclear angiotensin receptors and signaling mechanisms , 2012 .

[206]  Xie Xudong,et al.  Age- and gender-related difference of ACE2 expression in rat lung , 2005, Life Sciences.

[207]  T. Ogihara,et al.  Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. , 1999, Hypertension.

[208]  Merlin C. Thomas,et al.  Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse , 2010, Circulation research.

[209]  J. Penninger,et al.  Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[210]  D. Averill,et al.  Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors , 2004, Hypertension.

[211]  D. Sexton,et al.  MECHANISMS OF STEROID ACTION AND RESISTANCE IN INFLAMMATION Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma , 2003 .

[212]  Kenneth M. Baker,et al.  Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling , 2014, Journal of clinical medicine.

[213]  Rui-Zhen Shi,et al.  Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells. , 2009, Experimental cell research.

[214]  R. Tattersall,et al.  Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment , 2019, Rheumatology.

[215]  M. Sotoudeh,et al.  Lisinopril ameliorates paraquat-induced lung fibrosis. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[216]  J. Mocco,et al.  Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. , 2013, American journal of respiratory and critical care medicine.

[217]  K. Griendling,et al.  Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. , 2007, American journal of physiology. Cell physiology.

[218]  L. Navar,et al.  ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function , 2011, PloS one.

[219]  Y. Delneste,et al.  The roles of CSFs on the functional polarization of tumor‐associated macrophages , 2018, The FEBS journal.

[220]  M. Raizada,et al.  ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells. , 2015, American journal of physiology. Heart and circulatory physiology.

[221]  D. Harrison,et al.  Regulation of T-cell function by endogenously produced angiotensin II. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[222]  K. Tsubota,et al.  Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. , 2005, Investigative ophthalmology & visual science.

[223]  M. Huentelman,et al.  Protection from angiotensin II‐induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats , 2005, Experimental physiology.

[224]  É. Azoulay,et al.  Acute kidney injury in adults with hemophagocytic lymphohistiocytosis. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[225]  D. Gurwitz.  Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics , 2020, Drug development research.

[226]  L. Wolfe,et al.  Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. , 2007, Current pharmaceutical design.

[227]  Niku Oksala,et al.  ADAM-9, ADAM-15, and ADAM-17 are upregulated in macrophages in advanced human atherosclerotic plaques in aorta and carotid and femoral arteries—Tampere vascular study , 2009, Annals of medicine.

[228]  M. Goldstein,et al.  Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity , 2009, Proceedings of the National Academy of Sciences.

[229]  R. Kruse.  Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China , 2020, F1000Research.

[230]  P. Angus,et al.  Liver‐Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug‐Resistant Gene 2‐Knockout Mice , 2019, Hepatology communications.

[231]  N. El-Maraghy,et al.  Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade. , 2014, European journal of pharmacology.

[232]  Ralph S. Baric,et al.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.

[233]  J. Sowers,et al.  The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome. , 2017, The Medical clinics of North America.

[234]  S. Krähenbühl,et al.  Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects , 2013, Clinical Pharmacokinetics.

[235]  G. Su,et al.  [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia]. , 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[236]  Naftali Kaminski,et al.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[237]  K. Robison,et al.  A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 , 2000, Circulation research.

[238]  F. Lu,et al.  Correlation Analysis Between Disease Severity and Inflammation-related Parameters in Patients with COVID-19 Pneumonia , 2020, medRxiv.

[239]  Peng Ye,et al.  Inhibition of angiotension II type 1 receptor reduced human endothelial inflammation induced by low shear stress , 2017, Experimental cell research.

[240]  R. Stahl,et al.  Angiotensin II-Induced Mononuclear Leukocyte Interactions with Arteriolar and Venular Endothelium Are Mediated by the Release of Different CC Chemokines1 , 2006, The Journal of Immunology.

[241]  Jiagao Lv,et al.  Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection , 2020, Journal of the American Heart Association.

[242]  C. Donadoni,et al.  Effect of angiotensin II antagonism on the regression of kidney disease in the rat. , 2002, Kidney international.

[243]  M. Bristow,et al.  Angiotensin-(1-7) Formation in the Intact Human Heart: In Vivo Dependence on Angiotensin II as Substrate , 2003, Circulation.

[244]  Tsai-Jung Wu,et al.  Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[245]  C. Ferrario,et al.  Regulation of ACE2 in cardiac myocytes and fibroblasts. , 2008, American journal of physiology. Heart and circulatory physiology.

[246]  M. Han,et al.  Lactobacillus brevis G‐101 ameliorates colitis in mice by inhibiting NF‐κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2‐like macrophages , 2013, Journal of applied microbiology.

[247]  E. Gertner,et al.  Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome , 2020, ACR open rheumatology.

[248]  T. Sasazuki,et al.  Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry , 2008, Proceedings of the National Academy of Sciences.

[249]  M. F. Notter,et al.  Steroid hormone alteration of herpes simplex virus type 1 replication , 1978, Journal of medical virology.

[250]  G. Oudit,et al.  Cell-Specific Functions of ADAM17 Regulate the Progression of Thoracic Aortic Aneurysm , 2018, Circulation research.

[251]  J. Weidanz,et al.  AT1R blockade reduces IFN-γ production in lymphocytes in vivo and in vitro , 2005 .

[252]  J. Satoh,et al.  Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo , 1997 .

[253]  S. Keidar,et al.  ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[254]  Y. Li,et al.  Role of ADAM17 in the ectodomain shedding of TNF‐α and its receptors by neutrophils and macrophages , 2007, Journal of leukocyte biology.

[255]  M. Goddard,et al.  ACE2 gene expression is up-regulated in the human failing heart , 2004, BMC medicine.

[256]  Arthur S Slutsky,et al.  Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. , 2008, American journal of physiology. Heart and circulatory physiology.

[257]  E. Giamarellos‐Bourboulis,et al.  Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis , 2019, Front. Immunol..

[258]  J. Frøkiaer,et al.  Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. , 2007, American journal of physiology. Renal physiology.

[259]  P. Xie,et al.  Modulation of angiotensin II-induced inflammatory cytokines by the Epac1-Rap1A-NHE3 pathway: implications in renal tubular pathobiology. , 2014, American journal of physiology. Renal physiology.

[260]  L. Cassis,et al.  Deficiency of ACE2 in Bone-Marrow-Derived Cells Increases Expression of TNF-α in Adipose Stromal Cells and Augments Glucose Intolerance in Obese C57BL/6 Mice , 2012, International journal of hypertension.

[261]  J. Penninger,et al.  Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy , 2009, Diabetes.

[262]  K. Yamamoto,et al.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. , 2000, Genes & development.

[263]  Akram Khan,et al.  A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome , 2017, Critical Care.

[264]  S. van Calenbergh,et al.  Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts. , 2009, Arthritis and rheumatism.

[265]  R. Alsabeh,et al.  Angiotensin‐converting enzyme is required for normal myelopoiesis , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[266]  T. Brodie,et al.  Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. , 2001, The Journal of pharmacology and experimental therapeutics.

[267]  P. Rosenstiel,et al.  ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation , 2012, Nature.

[268]  Y. Peleg,et al.  Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo , 2016, Scientific Reports.

[269]  S. Rose-John,et al.  The Transmembrane CXC-Chemokine Ligand 16 Is Induced by IFN-γ and TNF-α and Shed by the Activity of the Disintegrin-Like Metalloproteinase ADAM10 1 , 2004, The Journal of Immunology.

[270]  R. Schmieder,et al.  Additional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study. , 2005, Journal of the American Society of Nephrology : JASN.

[271]  S. Sriramula,et al.  Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension , 2017, Circulation research.

[272]  F. De Benedetti,et al.  Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome , 2017, Pediatric Rheumatology.

[273]  A. López-Guillermo,et al.  Adult haemophagocytic syndrome , 2014, The Lancet.

[274]  C. Blobel,et al.  iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS , 2012, Science.

[275]  D. Diz,et al.  Angiotensin-(1-7)–Angiotensin-Converting Enzyme 2 Attenuates Reactive Oxygen Species Formation to Angiotensin II Within the Cell Nucleus , 2009, Hypertension.

[276]  Yulin Li,et al.  Angiotensin II induces inflammation leading to cardiac remodeling. , 2012, Frontiers in bioscience.

[277]  R. Guo,et al.  Angiotensin II induces NF-κB activation in HUVEC via the p38MAPK pathway , 2006, Peptides.

[278]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[279]  M. Donoghue,et al.  Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. , 2006, The Journal of clinical investigation.

[280]  R. Schleimer,et al.  Glucocorticoids Enhance or Spare Innate Immunity: Effects in Airway Epithelium Are Mediated by CCAAT/Enhancer Binding Proteins1 , 2007, The Journal of Immunology.

[281]  S. Davidge,et al.  Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage. , 2017, Journal of molecular and cellular cardiology.

[282]  R. Hynes,et al.  The Lack of ADAM17 Activity during Embryonic Development Causes Hemorrhage and Impairs Vessel Formation , 2010, PloS one.

[283]  I. Haznedaroglu,et al.  Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignancies. , 2016, European review for medical and pharmacological sciences.

[284]  A. Ramanan,et al.  Macrophage Activation Syndrome , 2016, The Indian Journal of Pediatrics.